During the past decade, The Centre for Memory and Aging conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Centre for Memory and Aging" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "JHSPH Center for Clinical Trials" with 1 trials sponsored and "McGill University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Centre for Memory and Aging" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Alberta Prion Research Institute" with 1 trials as a collaborator, "Alzheimer Society of Canada" with 1 trials as a collaborator and "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "The Centre for Memory and Aging" are "Alzheimer's Disease" (9 trials), "Dementia" (2 trials), "Alzheimer Disease" (1 trials) and "Alzheimers Disease" (1 trials). Many other conditions were trialed in "The Centre for Memory and Aging" in a lesser frequency.

Most popular intervention types in "The Centre for Memory and Aging" are "Drug" (12 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Crenezumab" (3 trials), "Gantenerumab" (2 trials), "Alum" (1 trials) and "Bapineuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Centre for Memory and Aging" are 13 trials for "All" genders.

Currently, there are NaN active trials in "The Centre for Memory and Aging". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in The Centre for Memory and Aging, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in The Centre for Memory and Aging, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".